BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 13, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 8, 2006
View Archived Issues
Genentech recaps Q1 highlights
Read More
Quarterly activities at Gilead Sciences
Read More
No statistical significance for intranasal ketamine in postoperative pain study
Read More
Avigen's glial inhibitor reverses neuropathic pain symptoms
Read More
Genzyme and Brookwood team up to offer drug delivery solutions
Read More
Preclinical data presented on bicifadine in models of neuropathic pain
Read More
Epidural NGX-424 relieves postoperative pain in vivo
Read More
PPARgamma agonists a novel strategy for neuropathic pain
Read More
Protox begins phase I study of PRX-302 in localized recurrent prostate cancer
Read More
NicOx studies 24-hour blood pressure profile of HCT-3012
Read More
Completion of phase II study of leuprolide acetate in male Alzheimer's patients
Read More
BioAlliance Pharma establishes new sales and marketing subsidiary
Read More
AEterna Zentaris and U. of Montreal collaborate on ghrelin research
Read More
New phase III study to evaluate Telcyta with Doxil in ovarian cancer
Read More
Molecular Pharmacology reports on new topical COX-2 inhibitor MPL-356
Read More
Hollis-Eden plans phase I for Neumune in hospital-acquired infections
Read More
Solvay and Innogenetics renew research collaboration for further three years
Read More
AstraZeneca discontinues development of Galida
Read More
Phase IIb studies of bremelanotide in erectile dysfunction complete enrollment
Read More
ImmunoGen and Genentech sign new TAP agreements
Read More
Protalex completes phase I study of PRTX-100
Read More
MAA submission for prolonged-release paliperidone for schizophrenia
Read More
European approval for Valtropin
Read More
Recent patents disclose novel therapeutic agents for gastrointestinal disorders
Read More
Recent patents report new treatments for psychological disorders
Read More
Novel therapeutic agents imparted for inflammatory disorders
Read More
The marine product misakinolide A could be useful in glaucoma therapy
Read More
Geranylgeranyltransferase type I, a potential therapeutic target in glaucoma
Read More
Snapshots on novel therapeutic strategies for choroidal neovascularization
Read More